Navigation Links
Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
Date:11/23/2009

ALISO VIEJO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International (NYSE: VRX), today announced that it has now launched chlordiazepoxide hydrochloride and clidinium bromide, an authorized generic (AG) version of Librax®. Oceanside has received its first orders and expects to be a significant player in the Librax® generic market.

"Valeant's Oceanside unit has become an important division of our U.S. business with its successful launch and distribution of 5% fluorouracil, Valeant's authorized generic of Efudex®," stated J. Michael Pearson, chairman and chief executive officer. "Oceanside currently maintains a 55% market share of its Efudex® AG and plans to retain this leadership position in the future. With the industry experience we have had with Efudex® AG, we believe that we can successfully grow a strong market position with the launch of Librax® AG."

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements, including, but not limited to, statements regarding Oceanside's launch and growth of Librax AG and Oceanside's strong leadership position with Efudex AG. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "shoul
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015 As ... "Bionics Market - Global Industry Analysis, Size, Share, Growth, Trends ... at USD 7.96 billion in 2014, growing at a CAGR ... 20.49 billion in 2021. The global bionics market ... of accidents, which is leading to paralysis or amputation of ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ) has announced ... Asia/Pacific Markets Seminar" conference to their offering. ... is well established, the next growth area is ... together with other countries in this region have all ... own medical device regulations. This seminar will provide a ...
(Date:7/27/2015)... 17, 2015 Research and Markets ( ... "G-Protein Coupled Receptors Market: Global Industry Analysis, ... 2022" report to their offering. ... based on of assay type, therapeutic area, and ... has been categorized into six major segments: cAMP ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2
(Date:7/28/2015)... Florida (PRWEB) , ... July 28, 2015 , ... ... America's trusted source for identifying Top Doctors, has based its selection process on ... the most outstanding in their medical specialties, in any area of medicine and ...
(Date:7/28/2015)... ... July 28, 2015 , ... Maryland Brain & Spine has ... along with it, more service offerings, updated treatment techniques, and additional state-of-the art online ... management and minimally invasive surgical treatment of brain and spine conditions. , “Adding ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Advanced Fertility ... organization’s inception in 2010, and Dr Dozortsev , a Reproductive Laboratory Director ... president. In 2012, he was succeeded by Dr Gianpiero Palermo, who is credited with ...
(Date:7/28/2015)... ... July 28, 2015 , ... The joint SCAN ... such as reducing high-risk medication use and improving compliance with diabetes treatment guidelines. ... behaviors and outcomes, this unique-in-the-industry Quality Network Program may be paving the way ...
(Date:7/28/2015)... ... 28, 2015 , ... American Sentinel University has been named ... for Geisinger Health System (GHS), one of the nation’s largest integrated health services ... with access to American Sentinel’s affordable, flexible and CCNE-accredited RN to BSN nursing ...
Breaking Medicine News(10 mins):Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2Health News:SCAN/Express Scripts MA Pharmacy Quality Network Program to be Featured in Upcoming AIS Webinar 2Health News:SCAN/Express Scripts MA Pharmacy Quality Network Program to be Featured in Upcoming AIS Webinar 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 4
... Novel protocol could provide new lung tissue for certain ... -- Belgian scientists who used embryonic stem cells to ... alternative to lung transplants for patients with chronic obstructive ... is the first time it,s been shown that embryonic ...
... ... BWIN™, and WaveRider® Product Lines , ... (PRWEB) November 6, 2009 -- WAV, Inc., the ... it has partnered with Vecima Networks Inc. (TSX:VCM), a leading provider of equipment ...
... of protests and arrests. , WASHINGTON, Nov. 6 ... Pelosi,s office for tearing up the "Health Care" bill. They ... and William Kee. , Hearing to be held at ... P.M., Friday, November 6, these five pro-life advocates will appear ...
... , PHILADELPHIA, Nov. 6 In a newly-published special ... hospital policies to prevent and treat venous thromboembolism (VTE), ... throughout the world. Lippincott Williams & Wilkins ... VTE, a disease that includes both the common medical ...
... Congressman Fattah releases the following statement in observance of Pancreatic ... is a rare and perplexing disease, yet it is the fourth ... year, more than 42,000 Americans will be diagnosed with the disease ... far too high. , "To find a cure for pancreatic ...
... role in boosting memories -- or forgetting them, researchers say ... remember the first time you smelled a type of flower? ... brain might. , In the study, published online Nov. ... objects to adult study participants. They paired the objects with ...
Cached Medicine News:Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 2Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 3Health News:New Smells 'Etched' in Brain: Study 2
... enzymatic cleaner is a fast-acting ... stubborn deposits in as little ... enzymatic cleaner contains an enzyme ... film on soft contact lenses ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Sterile cordless eraser tips, packsize is 10/box....
Medicine Products: